News Coverage - Parker Institute for Cancer Immunotherapy

Research
Network
News
About
Donate

Research
Network
- Research Institutions
  Our academic collaborators’ seminal contributions push the field forward
- Directory
  Our constellation of renowned thinkers and partners
- Strategic Partnerships
  The right collaborators across pharma, biotech and nonprofit
- Early Career Researcher Awards
  The next generation of scientific leaders in cancer immunotherapy
News
- News Menu
  - The Latest
    Stories & Announcements
  - News Coverage
    PICI in the News
  - Podcast
    From Bench to Fireside
  - For Media
    Resources for Press
About
- Mission & Vision
  Develop breakthrough immune therapies to turn all cancers into curable diseases faster
- Leadership & Staff
  The driving force behind PICI’s research and operations
- Careers
  Join us. Change lives.
Donate

The Chronicle of Philanthropy

06.28.17

Grants Roundup

Read

PharmaBiz

06.19.17

Tessa Therapeutics, Parker Institute partner to jointly advance research in cancer immunotherapy

Read

Biospace.org

06.19.17

Bay Area Tech Titan Sean Parker Reaches Out to Unheard-Of Biotech to Confront Immunotherapy

Read

BioCentury

06.19.17

Parker Institute, Tessa in Cell Therapy Deal

Read

EndPoints

06.19.17

Billionaire-backed Parker Institute tackles the Holy Grail of cancer R&D — with a virtual unknown

Read

FierceBiotech

06.19.17

Parker-Tessa alliance tees up solid tumor I-O combinations

Read

Philadelphia Magazine

06.17.17

Welcome to Cellacon Valley?

Read

ecancer News

06.09.17

Back ASCO 2017: Higher gut bacteria diversity tied to slower metastatic melanoma progression

Read

BioCentury

06.08.17

The Bio-Tech Bridge – How Tech Philanthropists Are Becoming New Players In The Biotech Ecosystem

Read

Life Science Leader

06.07.17

IO KOLs Speak On

Read

STAT News

06.06.17

Identifying another of cancer’s wily tricks: Masking pain so tumors can grow unnoticed

Read

FierceBiotech

05.25.17

Using CRISPR gene editing to slow cancer growth

Read